U.S. Preventive Services Task Force Expands Recommendations For Women To Be Tested For BRCA Mutations

The influential panel of experts says that women with previous breast, ovarian, fallopian-tube or abdominal cancer diagnoses who have completed treatment should be assessed for mutations of the BRCA1 and BRCA2 genes, as should women with ancestry more predisposed to those mutations.

from Kaiser Health News https://ift.tt/2HiSyfV